
Engineered Viruses Make Neurons Glow and Treat Brain Disease
This newfound diversity is not only a beautiful picture for neuroscientists—it's also key to understanding how the brain works and what goes wrong in certain brain diseases. From Parkinson's disease to schizophrenia, many brain disorders stem from specific types of brain cells.
'As long as I've been doing neuroscience, it's been a goal of researchers to have brain-cell-type-targeting tools,' says Jonathan Ting of the Allen Institute, a nonprofit research center in Seattle. Now they have them in spades. In a fleet of eight studies funded by the National Institutes of Health and published last week, scientists from 29 research institutions found and tested more than 1,000 new ways to home in on specific cell types, no matter where they are in the brain.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
The technique behind these tools uses non-disease-causing viruses (called adeno-associated viruses, or AAVs) to deliver genes directly to specific neurons. This can make the cells do almost anything. Scientists can turn them off, activate them, 'light them up like a Christmas tree' with glowing proteins or deliver gene therapies right to them, says Ting, senior author of one of the new studies. The researchers have tested the technique only in nonhuman animals, but the bulk of the tools work across mammal species and would likely work in humans, too. Similar, less-targeted AAV gene therapies are already approved for treating spinal muscular atrophy and are being tested in clinical trials for Huntington's disease.
'There are a lot of good examples' of how AAVs are being used to treat brain disease, says Nikolaus McFarland, a neurologist at the University of Florida, who treats neurodegenerative diseases such as Parkinson's and Huntington's. 'It's really exciting stuff.'
Viral Shuttles
Every type of brain cell is like a unique creature. Scientists have categorized the cells based on their shape, location and electrical properties—and, more generally, based on the genes they express most out of an organism's full library of DNA. By expressing certain genes, these cells carry out specific actions, such as building specialized proteins. If researchers can identify a unique snippet of genetic code that is activated just in those cells, they can use that snippet to target them.
Next, they attach this genetic snippet, called an enhancer, to an AAV that has been gutted of its viral DNA. They can fill the viral husk with specific genes to deliver to those cells. The now-filled husks enter the bloodstream like a fleet of delivery shuttles, bypassing the blood-brain barrier, but are only able to activate their genetic cargo in cells with the enhancer.
In the new studies, researchers focused on cell types in three parts of the brain: the outer layer of brain tissue called the cortex that plays a role in higher-level thinking, the striatum, which is part of the basal ganglia (a stretch of deep brain tissue) that is impacted in Huntington's and Parkinson's disease, and the spinal cord, whose motor neurons are destroyed in amyotrophic lateral sclerosis (ALS). The consortium of 247 scientists was funded by the NIH's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative as a part of a larger research project called the Armamentarium for Precision Brain Cell Access. The scientists found and tested more than 1,000 enhancer AAVs, now freely available to researchers, that target specific cell types in those key brain regions.
Tweaking the Brain
Previously, these enhancer AAVs had been developed in a slow trickle by different labs, but 'now we have thousands of tools' to tweak specific cell types, says Bosiljka Tasic, director of molecular genetics at the Allen Institute and senior author of one of the new studies.
Researchers can load these AAV shuttles with all sorts of different genes to answer different questions. In some cases, even just seeing the neurons in action is cause for celebration: 'Some of them are very rare cells that you wouldn't find randomly by poking around in brain tissue,' Ting says. To observe them, researchers can introduce a gene that makes a glowing protein that lights up elusive neurons from the inside to reveal their structure and how they connect with other brain cells.
Researchers can also control how certain brain cells fire and turn their activity up or down to see how the change impacts an animal's behavior. To do this, researchers insert a gene into the target cells that creates a light-sensitive protein called an opsin; then they can shine specific wavelengths of light on the brain to make those cells fire on command. Ting's team used this technique, called optogenetics, to stimulate certain cells in the striatum of mice. When the researchers stimulated those cells on just one side of the brain, the mice began moving more on one side of their body than the other, causing them to go in circles.
These interventions are reversible and repeatable. 'That's the part that's really satisfying for neuroscientists,' Ting says. 'You can turn them off, turn them back on and then see how that affects the brain circuit.'
It's ' so much better and also so much more informative' than destroying whole parts of a mouse brain to see what happens, as is the case with much neuroscience research from the past century, Tasic says. 'That brain region may have a hundred different cell types,' so being able to activate and inactivate them more precisely will reveal more information about how these circuits work, she says.
New Treatments
So far, the new enhancer AAVs have been tested in mice, rats and macaques. 'We keep trying more and more species,' Ting says. 'We haven't even figured out what's the limit.'
And that brings us to humans. 'That's really the answer to the question 'Why do we care?'' he says. 'We have built strong evidence that some of these tools—maybe not all of them, but many of them—may work across species into humans and could represent the start of a new therapeutic vector development that could be used to more finely treat debilitating brain disorders.'
For these treatments, enhancer AAVs could deliver gene therapy right to the brain cells that need it. The best candidates for this technique are neurodegenerative diseases, such as ALS, Parkinson's disease and Huntington's disease. Researchers are currently working on AAV gene therapies for these conditions and others that target whole regions of the brain rather than specific types of brain cells. Trials of these therapies indicate that they are largely safe. 'We now have lots of good examples of AAV being used,' McFarland says. 'We have [a] good safety record for that.'
'There's a lot that we still don't understand about neurodegenerative diseases,' he adds, and these little viral shuttles will allow scientists to make those discoveries that enable new treatments. While each of these brain disorders is unique, cracking one of them might help scientists crack the others, too, McFarland says: 'I wholeheartedly believe that.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


UPI
5 hours ago
- UPI
The difference between palliative care and hospice
If a doctor diagnoses you with a serious illness and suggests palliative care, don't jump to conclusions. It doesn't mean you have mere months to live, NIH News in Health emphasizes. Palliative care, which is focused on comfort care and symptom management, may be recommended at any stage of a chronic or serious illness. But it is often confused with hospice care, which is comfort care for patients in the final months of life and requires that all treatments be discontinued. "Embracing palliative care does not mean that you're giving up on treatment," said Alexis Bakos, an aging expert at the National Institutes of Health. "Ideally, palliative care should be offered at the very beginning of a diagnosis of any serious illness." Diagnoses like chronic heart and lung disease, cancer and neurodegenerative illnesses like dementia and Parkinson's all fall under the definition of "serious." These illnesses lower a patient's quality of life or ability to perform everyday tasks like cooking or bathing. A palliative care team can help patients cope with physical, psychological, emotional or spiritual suffering associated with these diagnoses, according to News in Health. They can not only help patients manage symptoms but also assist providers in coordinating complex care. Dr. Matthew DeCamp, a physician at the University of Colorado, Anschutz Medical Campus, describes palliative care as a "holistic approach" to medicine and caregiving. "It places the patient's quality of life and needs and values front and center," he told News in Health. A pallative care provider typically meets with a patient soon after they are diagnosed with a serious disease to explain the many ways they can lend a hand - from help coordinating care to helping patients create an advance directive, which spells out their wishes for care if they become unable to speak for themselves. "They will learn your preferences for care and communication," said Dr. Lori Wiener, a palliative care expert at the NIH. Many patients welcome the assist, because planning for a serious illness is often complicated. "Patients and families often remain unaware of how their serious illness may progress," DeCamp said. "They may not know how long they might be expected to live or how long or what types of symptoms they might have. Physicians, nurses and other members of the care team are also historically not very good at predicting the course of a disease." These days, AI tools can help with that. But not all doctors use them and when they do, patients might misinterpret findings they spot in their medical records, said DeCamp, who is studying ethical issues surrounding use of AI. Weiner's team, which is studying ways to help kids with cancer communicate their wishes to family and health care providers, has created a guide called "Voicing My CHOiCES" that helps teens and young adults consider and spell out their hopes, fears and values. It has also developed an electronic screening tool called "Checking IN," which helps doctors understand what, specifically, distresses their young patients so they can be better prepared for visits. Palliative care specialists can help patients understand their prognosis and their treatment options - and help them be comfortable. So NIH experts urge patients who are diagnosed with serious illnesses to ask their doctor about palliative care if it isn't offered to them right away. "Earlier NIH research was focused on making sure that primary care clinicians were aware of palliative care," Bakos said, adding that NIH is looking now at ways to involve more specialists such as E.R. doctors, neurologists and ICU providers into discussions of palliative care. More information Learn more about palliative care and hospice at the National Institute on Aging. Copyright © 2025 HealthDay. All rights reserved.

Business Insider
10 hours ago
- Business Insider
The under-the-radar injections people are taking to build muscle this summer — including the 'Wolverine' shot
Peptide injections are soaring in popularity for fitness and longevity. They're marketed as a "natural" supplement for muscle-building, fat loss, recovery, and more. The FDA has been cracking down on peptide sellers, and experts say some caution is warranted. People who want to feel younger, look fitter, or perhaps slough off a little layer of belly fat have been turning to an increasingly popular kind of treatment — one you can get without a prescription. They've got obscure names like BPC-157, tesamorelin, and cerebrolysin. All it takes is a tiny needle and a little clear vial filled with injectable molecules. Welcome to the world of peptides. "Absolutely everybody's asking for it, the field is popping," Dr. Florence Comite, a longevity doctor who serves concierge medicine clients in New York City, told Business Insider. The peptide landscape is so large that it almost defies definition. The prescription drugs Ozempic and Mounjaro, often used for weight loss, are peptides. So is insulin. There are peptides in skin creams, hair products, and high-end serums marketed to women to reduce fine lines and stimulate collagen. The wildly popular fitness supplement creatine? Also a peptide. Then, there are the gym bro shots, said to boost muscle, burn fat, stimulate testosterone, and aid recovery. Demand for peptide injections — something that biohackers and longevity-seekers have already been quietly using in the shadows for decades — is booming. Patients in pockets of the country saturated with peptides, like Beverly Hills, San Diego, Silicon Valley, and Manhattan are increasingly asking their doctors: "should I try peptides?" Many physicians aren't sure what to say because there isn't a ton of great evidence around about how much peptides can really do. Plus, the FDA has been cracking down on peptide compounders in recent years. They worry that the hype is outpacing good evidence. How peptides boost your body Unlike most pills that doctors prescribe, peptides live in a more slippery area, between drug and bodily substance. A peptide is a chain of organic compounds — specifically, amino acids — that stimulate natural processes. Depending on which amino acids a peptide is made of, and how it is used, the molecule can have all kinds of impacts on how our hormones operate. Peptides can improve fertility in both men and women, tamp down inflammation, remove dangerous visceral belly fat, or help build muscle. Others are thought to help improve sleep quality, even possibly improve brain health. "What's great about peptides is that they mimic the body," said Comite, who has been working with peptides since she was a research fellow at the National Institutes of Health over 30 years ago. Since most peptides are too fragile to be formulated as pills, they are often packaged as a clear liquid in a little vial. Users learn to inject their peptides using a very fine, short needle, right at home. The popularity of peptides has soared on their reputation as ostensibly "natural" products. The idea being that, unlike other drugs or steroids, peptides are a safer choice because they're just stimulating your body to do its own thing. Taking growth hormones, for example, comes with a suite of undesirable potential side effects, like an increased risk of cancer and type 2 diabetes. What if you could just take a peptide that would stimulate your own growth hormone to make you stronger, leaner, and more energetic? "The theory is that even if you use a growth hormone stimulating peptide, your body's only going to be able to make so much growth hormone," Dr. Sajad Zalzala, a longevity physician and one of the cofounders of AgelessRx, said. "Kind of like a check valve already in place. Again, that's the theory." The peptides gym bros take to get chiseled muscles One darling peptide of gym bros and longevity fiends alike is a substance called BPC-157. It's known as the "Wolverine" shot for its perceived ability to heal you up and regenerate your body real fast like the Marvel character, Logan, after a big fight. B-P-C stands for "body protection compound." BPC-157 was first derived from stomach juices. It's being investigated to treat inflammatory bowel diseases, including Crohn's and ulcerative colitis. But the reason that athletes like it is because it's thought to reduce inflammation and improve blood flow — and perhaps do even more. There are a few other super popular peptides: Tesamorelin, an injectable peptide, is prescribed to HIV patients to reduce excess belly fat. Sermorelin is supposed to help with sleep and recovery. CJC-1295 binds to growth hormone receptors in the body, and people often take it alongside impamorelin, which stimulates the hypothalamus. The two in tandem are said to deliver better muscle gains. On Reddit and YouTube people share how they "stack" different peptides like this, taking multiple different kinds with the goal of boosting the effects of each. Peptide fans get their shots at clinics and med spas — or, for less money, online. Increasingly, people are ordering peptides that are labeled "for research only," meaning they are supposed to be used by lab workers for experimentation, and were never meant to be put into human bodies. That's partly because the FDA crackdown on peptides has intensified in recent years, just as pharmaceutical compounding (a sort of acceptable way to get knock off medications) has surged in popularity, with people seeking cheaper versions of GLP-1 drugs like Ozempic and Mounjaro. At the beginning of 2022, the FDA had a list of four peptides that they said "may present significant safety risks" and should not be compounded. By the end of 2023, there were 26. Comite thinks the FDA crackdown is a shame. She is finding it harder and harder to source compounded liquid BPC-157. She often uses a patch form of BPC-157 on herself, placing it over sore areas or injuries. Recently, she tore a calf muscle, so she's been using it there, but she also just likes how taking a little bit of it keeps her active and moving. "I use it almost every day," she said. "It's amazing for joints and everything — at a very tiny dose." Zalzala, who doesn't usually prescribe peptides, ordered some topical BPC-157 recently when his wife had a knee injury. "My wife says it works," he said, though he cautioned that it's hard to really know if that's true without more proper research. Bracken Darrell, the CEO of VF Corporation and one of Comite's patients, is also a BPC-157 convert. A self-proclaimed "basketball nut," he's on the court about three days a week. On the days when he doesn't pick up a ball, he's out cross-training on a bike or lifting weights. So when he tore his meniscus about four months ago, he was worried. Under Comite's supervision, he started taking liquid BPC-157 about three to four times a week. He told BI it was "weird" at first, learning to inject the needle into an area of skin near his knee. But, pretty soon, it was just part of his routine. "I believe it helped a lot, but it's hard to know for sure," he said. "There are people with a severely torn meniscus who don't ever play basketball again, and I'm back — I certainly wouldn't conclude that's because I'm taking BPC-157, but at a minimum it didn't hurt. And it sure seems like it helps." Proceed with caution, doctors say Even longevity doctors who prescribe and use peptides regularly agree that some folks are overdoing it, and that could be dangerous. "Proceed with caution, because you have to know the source and you have to know it's active," Comite said. "It's not like Lowe's or Home Depot where you can get stuff and you can fix the plumbing." In reality, the evidence for peptides is still murky. There are no big, randomized clinical trials like what we have for prescription drugs or vaccines. The current hype is based on anecdotal evidence, a few small human studies from decades ago, and rodent studies. "People wanna take the peptides because they're not from big pharma, they're not mainstream medicine, they gotta be better than those cockamamie doctors," Dr. Eric Topol, a cardiologist and longevity expert, said recently on the Dax Shepard podcast. "Where's the data?" For people who are using peptides, experts shared two pieces of advice: Comite urges patients to start slow. A common mistake people who are dosing themselves make is thinking that "if a little bit is good, then a lot must be better," she said. That's not the case. "Taking mega doses of tesmorelin along with testosterone causes your organs to overgrow," Comite said. Sometimes she'll see a toned gymgoer with a potbelly, and wonder whether that's due to an enlarged liver or spleen. Darrell recommends testing your peptides with an independent lab so you know what you're getting is both real and uncontaminated. Zalzala says his company started thinking about offering peptides a few years back, due to consumer demand, but they haven't yet. There are just so many peptides out there, and it's hard to tell which might be the very best. Some of the most research-backed ways to have an impact on your longevity and fitness are still the simplest anyway: eat decent amounts of fiber and protein regularly, work out — at least a couple sessions with weights each week, and cut back (or ideally, eliminate) liquid sugar in your diet like juice and soda.


The Hill
a day ago
- The Hill
GOP senators urge White House to release delayed NIH funding
Sen. Katie Britt (R-Ala.) and 13 other Senate Republicans are urging the Trump administration to release National Institutes of Health (NIH) funding that has been held up for months. The GOP senators warned in a letter to White House budget chief Russell Vought that the 'slow disbursement of funds' that Congress appropriated in March 'risks undermining critical research and the thousands of American jobs it supports.' 'Suspension of these appropriated funds — whether formally withheld or functionally delayed — could threaten Americans' ability to access better treatments and limit our nation's leadership in biomedical science,' the senators warned. 'It also risks inadvertently severing ongoing NIH-funded research prior to actionable results,' they wrote. The Trump administration suspended or cut many NIH research grants earlier this year in order to undertake a thorough review to ensure they complied with Trump's orders to end federal support for diversity, equity and inclusion (DEI) programs. A database set up by a Harvard University researcher estimated that by the end of May more than 2,100 NIH grants worth more than $9 billion had been cancelled. NIH Director Jay Bhattacharya told senators in March at his confirmation hearing that his agency would restart grant reviews but an analysis by STAT, a health care news site, last month found that NIH had made little progress in narrowing the funding gap created by the freeze on grant approvals. Now Republican senators are trying to ramp up pressure on the Office of Management and Budget. They told Vought that they share his commitment to ensuring NIH funds are 'used responsibly and not diverted to ideological or unaccountable programs.' But they also argued that starving the NIH of funding could inadvertently undermine trust in the agency. 'Withholding or suspending these funds would jeopardize that trust and hinder progress on critical health challenges facing our nation. Ultimately, this is about finding cures and seeing them through to fruition,' the senators wrote. 'We respectfully request that you ensure the timely release of all FY25 NIH appropriations in accordance with congressional intent,' they added. The other GOP signatories were Sens. John Boozman (Ark.), Shelley Moore Capito ( Bill Cassidy (La.), Susan Collins (Maine), Lindsey Graham (S.C.), David McCormick (Pa.), Mitch McConnell (Ky.), Jerry Moran (Kansas), Lisa Murkowski (Alaska), Thom Tillis (N.C.), Todd Young (Ind.), Dan Sullivan (Alaska) and Tim Scott (S.C.).